Timing & pharmacokinetics
How long does Kava take to work?
Onset timing for Kava varies in the clinical literature. Onset timing is not well-quantified in our dataset, refer to clinical citations on the main entry.
Onset
–
Half-life
9h
Duration
–
Timing
evening / before social
Key facts
- typical dose
- 100–300 mg
- dose frequency
- as needed
- timing
- evening / before social
- with food
- optional
- half-life
- 9 hours
- safety score
- 2/5
- evidence grade
- A
- class
- adaptogen
- PubMed citations
- 600
- legal status (US)
- Over-the-counter
- legal status (UK)
- Over-the-counter
- legal status (EU)
- Over-the-counter
- legal status (AU)
- Prescription-only
- primary mechanism
- Kavalactones, particularly kavain, methysticin, and yangonin, bind GABA-A receptors at a site distinct from benzodiazepines, plus modulate dopamine and noradrenergic systems.
Onset window
Kava onset times in the published literature vary widely. Refer to the citations on the main Kava entry for compound-specific pharmacokinetic data.
Food effect: Food has only modest effect on Kava onset. Take with or without food depending on GI tolerance.
Half-life and dosing frequency
Long 9-hour half-life, daily morning dose is enough; avoid afternoon dosing if you are sleep-sensitive.
Acute vs. chronic effect
Some nootropics work the first time you take them (Kava may or may not). Others, adaptogens, racetams, and most botanicals targeting BDNF or NGF pathways, require 2–4 weeks of daily dosing before the full effect emerges.
If you don’t feel anything after a single dose and the compound is in the chronic-effect category, that is normal, extend the trial to 2–4 weeks before evaluating. If it is in the acute category and you feel nothing, consider dose, vendor sourcing, or whether the compound matches your goal.
Protocol note from the Kava entry
Use noble cultivars only. Avoid with alcohol or hepatotoxic meds.
Mechanism, safety, and citations for Kava are on the main reference page, see Kava. For full dose protocol see Kava dosage. To check for stack-level pharmacokinetic conflicts, use the interaction checker.
Onset and pharmacokinetic data reflect the published literature for healthy adults at typical doses. Individual variation in absorption, metabolism (CYP genotype), and gut transit can shift onset by ±50%. This page is informational and not medical advice. See our full disclaimer.